ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.89
0.70%
US Tech 100
18,066.00
-0.07%
S&P 500
5,303.27
0.12%
US Dollar vs CAD
1.36135
-0.01%
Bitcoin
66,871.12
2.50%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Australia
  5. ASX
  6. Brumby Res Fpo (BMY)

  7. Brumby Res Fpo (BMY) News

BMY

Brumby Resources (BMY)

Brumby Res Fpo
Date:
Sort by:
 Showing the most relevant articles for your search:ASX:BMY
DateTimeSourceHeadlineSymbolCompany
10/16/20093:56PMDow Jones NewsUPDATE: Bristol-Myers Cuts Abilify Sales Force By About 25%NYSE:BMYBristol-Myers Squibb Co.
10/16/20098:29AMDow Jones NewsBristol-Myers Reduces Abilify Sales Force By About 25%NYSE:BMYBristol-Myers Squibb Co.
10/05/200910:04AMDow Jones NewsEU OKs AstraZeneca, Bristol Diabetes Drug For MarketingNYSE:BMYBristol-Myers Squibb Co.
10/05/20099:23AMDow Jones NewsAstraZeneca: Onglyza EU Marketing AuthorisationNYSE:BMYBristol-Myers Squibb Co.
10/02/20094:45AMDow Jones NewsAstraZeneca Reports Phase III Success For DapagliflozinNYSE:BMYBristol-Myers Squibb Co.
10/01/20093:48PMDow Jones NewsDiabetes Drug From Astra, Bristol Shows Benefit In StudyNYSE:BMYBristol-Myers Squibb Co.
09/29/20093:14PMDow Jones NewsUPDATE: Danone Denies Speculation Regarding Mead JohnsonNYSE:BMYBristol-Myers Squibb Co.
09/23/20099:22AMDow Jones NewsConflicting Erbitux Study Data Hurts Merck SharesNYSE:BMYBristol-Myers Squibb Co.
09/23/20098:22AMDow Jones NewsErbitux Succeeds In One Trial, Disappoints In AnotherNYSE:BMYBristol-Myers Squibb Co.
09/23/20094:59AMDow Jones NewsMerck Shares Rise On Positive Erbitux Data For Colon CancerNYSE:BMYBristol-Myers Squibb Co.
09/21/20091:52PMDow Jones NewsUPDATE:Lilly Drug Launch Seen Sluggish But CFO Sees ProgressNYSE:BMYBristol-Myers Squibb Co.
09/21/20091:28PMDow Jones NewsLilly Drug Launch Seen Sluggish But CFO Says Progress MadeNYSE:BMYBristol-Myers Squibb Co.
09/17/20098:31AMDow Jones NewsMerck KGaA's Erbitux Data May Be Upstaged By Rival VectibixNYSE:BMYBristol-Myers Squibb Co.
09/15/200911:29PMDow Jones NewsUPDATE:Taisho To Buy Bristol-Myers Asian OTC Assets For $310 MillionNYSE:BMYBristol-Myers Squibb Co.
09/15/200910:00PMDow Jones NewsTaisho Pharma: To Acquire Bristol-Myers OTC Rights In AsiaNYSE:BMYBristol-Myers Squibb Co.
09/08/20094:11PMDow Jones News3rd UPDATE:Facet Again Shuns Biogen Offer, Adopts Poison PillNYSE:BMYBristol-Myers Squibb Co.
09/08/200912:08PMDow Jones News2nd UPDATE:Facet Again Shuns Biogen Offer, Adopts Poison PillNYSE:BMYBristol-Myers Squibb Co.
09/08/200910:40AMDow Jones NewsUPDATE: Facet Again Shuns Biogen Offer, Adopts Poison PillNYSE:BMYBristol-Myers Squibb Co.
08/31/20095:30AMDow Jones NewsStudy: Popular Heartburn Drugs Don't Interfere With PlavixNYSE:BMYBristol-Myers Squibb Co.
08/30/20091:30AMDow Jones NewsHigh-Dose Plavix Misses Goal But Helps Some In StudyNYSE:BMYBristol-Myers Squibb Co.
08/28/20091:59PMDow Jones NewsUS EQUITIES WEEK AHEAD: Aug Jobs Data, Auto, Retail Sales DueNYSE:BMYBristol-Myers Squibb Co.
08/28/200910:46AMDow Jones NewsUPDATE: Boehringer's Blood-Thinner May Edge Out Bayer'sNYSE:BMYBristol-Myers Squibb Co.
08/28/20095:57AMDow Jones NewsBoehringer Ingelheim's Blood-Thinner May Edge Out Bayer'sNYSE:BMYBristol-Myers Squibb Co.
08/25/20094:12PMDow Jones NewsUPDATE: Study: Plavix Less Effective In Certain PatientsNYSE:BMYBristol-Myers Squibb Co.
08/25/20093:30PMDow Jones NewsJAMA Study Shows Plavix Ineffective In Certain PatientsNYSE:BMYBristol-Myers Squibb Co.
08/20/20094:42PMDow Jones NewsBristol-Myers Squibb Extends Medarex Tender Offer DeadlineNYSE:BMYBristol-Myers Squibb Co.
08/18/20096:53PMDow Jones NewsPreliminary Approval Given To Bristol-Myers Holder PactsNYSE:BMYBristol-Myers Squibb Co.
08/18/20093:51PMDow Jones News2nd UPDATE: US Patent Office Orders Re-Exam Of Plavix PatentNYSE:BMYBristol-Myers Squibb Co.
08/18/200912:06PMDow Jones NewsUPDATE: US Patent Office Orders Re-Exam Of Plavix PatentNYSE:BMYBristol-Myers Squibb Co.
08/18/200910:41AMDow Jones NewsUS Patent Office Orders Re-Examination Of Plavix PatentNYSE:BMYBristol-Myers Squibb Co.
 Showing the most relevant articles for your search:ASX:BMY

Your Recent History

LSE
KROP
Gx Agtechinnov
BIT
UC567Q
Unicredit Bank
BIT
UC7V2D
Unicredit Bank
AMEX
GOCT
FT Vest US Equity Modera...
EU
BE0002798792
Brussels Domestic bond 1...
BIT
UB6ZC5
Unicredit Bank
LSE
47EB
Arkle.60 Rgs
COIN
CSXUST
Coinstox Token
COIN
HYTETH
HoryouToken
DBI
AL8C
Dax 30 ESG
DBI
D1EP
DAXplus Export Strategy ...
LSE
80IO
Barclays 27
BIT
UC41G5
Unicredit Bank
COIN
TRAKGBP
TrakInvest
AMEX
BOSS
Global X Founder Run Com...
BOV
MERC3
MERCANTIL DO BRASIL ON
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved